methionine sulfoximine has been researched along with melphalan in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (45.65) | 18.7374 |
1990's | 24 (52.17) | 18.2507 |
2000's | 1 (2.17) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvero-Jackson, H; Benathan, M; Frenk, E; Mooy, AM; Scaletta, C | 1 |
Guenthner, TM; Jevtović-Todorović, V | 1 |
Alaoui-Jamali, MA; Batist, G; Centurioni, GM; Lehnert, S; Panasci, L; Schecter, R | 1 |
FitzGerald, GB; Prezioso, JA; Wick, MM | 1 |
Carp, N; Comis, RL; Hamilton, TC; LaCreta, FP; O'Dwyer, PJ; Ozols, RF; Padavic, K; Tew, KD; Young, RC | 1 |
Greig, NH; Rapoport, SI; Smith, QR; Takada, Y; Vistica, DT | 1 |
Awasthi, YC; Gupta, V; Medh, RD | 1 |
Bellamy, WT; Dalton, WS; Gleason, MC; Grogan, TM; Trent, JM | 1 |
Britten, RA; Broughton, C; Browning, PG; Green, JA; Warenius, HM; White, R | 1 |
Frankfurt, OS; Seckinger, D; Sugarbaker, EV | 2 |
Benz, CC; Ford, JM; Hait, WN; Matlin, SA | 1 |
Bigner, DD; Friedman, HS; Griffith, OW; McMahon, DP; Postels, DG; Skapek, SX; VanDellen, AF | 1 |
Hamilton, TC; O'Dwyer, PJ; Ozols, RF; Young, RC | 1 |
Gipp, JJ; McClelland, RA; Mulcahy, RT; Ublacker, GA | 1 |
Barranco, SC; Beasley, EG; Liu, NH; MacLean, KK; Schellenberg, K; Shaeffer, J; Townsend, CM; Weintraub, B | 1 |
Du, DL; Grieshaber, CK; Murphy, MJ; Volpe, DA | 1 |
DeGraff, W; Friedman, N; Mitchell, JB; Russo, A | 1 |
Bigner, DD; Bigner, SH; Colvin, OM; Elion, GB; Friedman, HS; Griffith, OW; Horton, JK; Lilley, E; Rosenberg, MC | 1 |
Ardiet, C; Navarro, C; Sapet, C; Tranchand, B | 1 |
Grieshaber, CK; Liao, JT; Page, JG; Smith, AC; Wientjes, MG | 1 |
Bigner, DD; Colvin, OM; Elion, GB; Friedman, HS; Griffith, OW; Hilton, J; Lippitz, B; Schold, SC | 1 |
Frankfurt, OS | 1 |
Deeg, HJ; Luk, K; Shulman, HM; Shuman, WB; Storb, R | 1 |
Roizin-Towle, L | 1 |
Hamilton, TC; Ozols, RF; Young, RC | 1 |
Edgren, M; Ehrsson, H; Hansson, J; Nilsson, B; Ringborg, U | 1 |
Bigner, DD; Colvin, OM; Elion, GB; Friedman, HS; Griffith, OW; Skapek, SX | 1 |
Dorr, RT | 1 |
Dorr, RT; Liddil, JD; Soble, MJ | 1 |
Cohen, GM; d'Arcy Doherty, M; Jordan, J | 1 |
Carmichael, J; DeGraff, W; Fisher, J; Friedman, N; Mitchell, JB; Phillips, T; Russo, A; Tochner, Z | 1 |
Behrens, BC; Dykes, D; Fine, RL; Hamilton, TC; Louie, KG; Ozols, RF; Plowman, J | 1 |
Ahmad, S; Greene, K; Kramer, RA; Vistica, DT | 1 |
Batist, G; Behrens, BC; Grotzinger, KR; Hamilton, TC; Louie, KG; McKoy, WM; Ozols, RF; Tsuruo, T; Winker, MA; Young, RC | 1 |
Biaglow, JE; Costello, T; Hall, EJ; Roizin-Towle, L; Varnes, ME | 1 |
Green, JA; Hamilton, TC; Ozols, RF; Rogan, AM; Vistica, DT; Young, RC | 1 |
Somfai-Relle, S; Suzukake, K; Vistica, BP; Vistica, DT | 1 |
Brennan, J; Gallo, JM; Halbherr, T; Hamilton, TC; Laub, PB; O'Dwyer, PJ; Ozols, RF | 1 |
Aloui-Jamali, MA; Batist, G; Lehnert, S; Vestergaard, J | 1 |
Beyers, KL; Siemann, DW | 1 |
Alberti, D; Arzoomanian, RZ; Bailey, HH; Mulcahy, RT; Pomplun, M; Spriggs, DR; Tombes, MB; Tutsch, KD; Wilding, G | 1 |
Canada, A; Herman, L; Kidd, K; Robertson, C; Trump, D | 1 |
Mulcahy, RT; Ripple, M; Wilding, G | 1 |
Bookman, MA; Brennan, J; Comis, RL; Gallo, JM; Halbherr, T; Hamilton, TC; Hoffman, J; Kilpatrick, D; LaCreta, FP; O'Dwyer, PJ; Ozols, RF; Young, RC | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
1 review(s) available for methionine sulfoximine and melphalan
Article | Year |
---|---|
The role of glutathione in drug resistance.
Topics: Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; DNA Repair; Drug Resistance; Female; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms | 1990 |
3 trial(s) available for methionine sulfoximine and melphalan
Article | Year |
---|---|
Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Enzyme Inhibitors; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Neoplasms; Neutrophils | 1995 |
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Female; Glutathione; Humans; Infusions, Intravenous; Male; Melphalan; Methionine Sulfoximine; Middle Aged; Neoplasms | 1994 |
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Buthionine Sulfoximine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Linear Models; Male; Melphalan; Methionine Sulfoximine; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Neutrophils; Radiography; Vomiting | 1996 |
42 other study(ies) available for methionine sulfoximine and melphalan
Article | Year |
---|---|
Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
Topics: Bucladesine; Buthionine Sulfoximine; Cell Differentiation; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Eye Neoplasms; Glutathione; Glutathione Transferase; Humans; Kinetics; Melanins; Melanoma; Melphalan; Methionine Sulfoximine; Microscopy, Electron; Monophenol Monooxygenase; Neoplasm Staging; Skin Neoplasms; Tumor Cells, Cultured | 1992 |
Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro.
Topics: Buthionine Sulfoximine; Carmustine; Cell Division; Cell Nucleus; Cytosol; Doxorubicin; Drug Synergism; Glutathione; Glutathione Disulfide; Humans; Melanoma; Melphalan; Methionine Sulfoximine; Oxidation-Reduction; Tumor Cells, Cultured | 1992 |
Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
Topics: Animals; Buthionine Sulfoximine; Cell Division; Cell Survival; Chlorambucil; DNA; Drug Interactions; Drug Resistance; Glutathione; Glutathione Transferase; Mammary Neoplasms, Experimental; Mechlorethamine; Melphalan; Methionine Sulfoximine; Rats; RNA, Messenger; Tumor Cells, Cultured | 1992 |
Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Dopamine; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Melanoma; Melanoma, Experimental; Melphalan; Methionine Sulfoximine; Mice; Tumor Cells, Cultured | 1992 |
Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Female; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Middle Aged; Neoplasms | 1992 |
Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.
Topics: 2-Naphthylamine; Amino Acid Transport Systems; Animals; Azaserine; Blood-Brain Barrier; Brain; Buthionine Sulfoximine; Carrier Proteins; Diazooxonorleucine; Isoxazoles; Male; Melphalan; Methionine Sulfoximine; Nitrogen Mustard Compounds; Rats; Rats, Inbred Strains | 1991 |
Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism.
Topics: Buthionine Sulfoximine; Cell Survival; Drug Resistance; Glutathione; Glutathione Transferase; Humans; Melphalan; Methionine Sulfoximine; Multiple Myeloma; Neoplasm Transplantation; Tumor Cells, Cultured | 1991 |
Development and characterization of a melphalan-resistant human multiple myeloma cell line.
Topics: Alkylating Agents; Buthionine Sulfoximine; Cell Survival; DNA, Neoplasm; Drug Resistance; Glutathione; Humans; Karyotyping; Melphalan; Methionine Sulfoximine; Multiple Myeloma; Myeloma Proteins; Tumor Cells, Cultured | 1991 |
The relationship between nuclear glutathione levels and resistance to melphalan in human ovarian tumour cells.
Topics: Buthionine Sulfoximine; Cell Nucleus; Drug Resistance; Female; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured | 1991 |
Intercellular transfer of drug resistance.
Topics: Antimetabolites; Buthionine Sulfoximine; Cell Communication; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; DNA; DNA Damage; Drug Resistance; Female; Flow Cytometry; Glutathione; Humans; In Vitro Techniques; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms; Tetradecanoylphorbol Acetate | 1991 |
Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers.
Topics: Alkylating Agents; Animals; Breast Neoplasms; Buthionine Sulfoximine; Carcinoma 256, Walker; Carmustine; Cell Division; Cell Line; Chlorambucil; Cisplatin; Drug Antagonism; Drug Resistance; Glutathione Transferase; Gossypol; Humans; In Vitro Techniques; Isomerism; Melphalan; Methionine Sulfoximine; Rats | 1991 |
Melphalan-induced toxicity in nude mice following pretreatment with buthionine sulfoximine.
Topics: Animals; Antimetabolites, Antineoplastic; Blood Cell Count; Buthionine Sulfoximine; Drug Synergism; Glutathione; Intestines; Kidney; Liver; Male; Melphalan; Methionine Sulfoximine; Mice; Mice, Nude; Muscles; Time Factors; Weight Loss | 1991 |
Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent.
Topics: Buthionine Sulfoximine; Cell Survival; Drug Synergism; Glutathione; Humans; In Vitro Techniques; Melphalan; Methionine Sulfoximine; Nitroimidazoles; Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.
Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Drug Screening Assays, Antitumor; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Stomach Neoplasms; Time Factors; Tumor Cells, Cultured | 1990 |
Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro.
Topics: Animals; Buthionine Sulfoximine; Colony-Forming Units Assay; Drug Synergism; Female; Hematopoietic Stem Cells; Humans; Melphalan; Methionine Sulfoximine; Mice; Time Factors | 1990 |
Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
Topics: Alkylating Agents; Antibodies, Monoclonal; Buthionine Sulfoximine; Cell Line; Cell Survival; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Resistance; Female; Flow Cytometry; Humans; Kinetics; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured | 1990 |
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
Topics: Antineoplastic Agents; Bleomycin; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cisplatin; Glutathione; Humans; Lung; Lung Neoplasms; Melphalan; Methionine Sulfoximine; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Zinostatin | 1986 |
Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
Topics: Animals; Buthionine Sulfoximine; Drug Interactions; Drug Resistance; Female; Glutathione; Glutathione Transferase; Humans; Male; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rhabdomyosarcoma; Transplantation, Heterologous; Vincristine | 1989 |
[Cellular pharmacokinetics of melphalan alone or in combination on human lymphoma or lymphoblasts].
Topics: Antimetabolites; Blastomeres; Burkitt Lymphoma; Buthionine Sulfoximine; Cell Line; Etoposide; Humans; Lymphocytes; Melphalan; Methionine Sulfoximine; Verapamil | 1989 |
Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
Topics: Administration, Oral; Animals; Buthionine Sulfoximine; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Interactions; Glutathione; Half-Life; Injections, Intravenous; Liver; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Premedication | 1989 |
Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.
Topics: Animals; Brain Neoplasms; Buthionine Sulfoximine; Drug Interactions; Female; Glioma; Glutathione; Humans; Male; Medulloblastoma; Melphalan; Methionine Sulfoximine; Mice; Mice, Nude; Neoplasm Transplantation | 1989 |
Detection of DNA damage in individual cells by flow cytometric analysis using anti-DNA monoclonal antibody.
Topics: Alkylating Agents; Antibodies, Monoclonal; Buthionine Sulfoximine; Cell Cycle; Cell Survival; DNA Damage; DNA, Single-Stranded; Endonucleases; Flow Cytometry; HeLa Cells; Hot Temperature; Humans; Melphalan; Methionine Sulfoximine; Nitrogen Mustard Compounds; Single-Strand Specific DNA and RNA Endonucleases | 1987 |
Induction of hepatic veno-occlusive disease in dogs.
Topics: Animals; Busulfan; Buthionine Sulfoximine; Cyclophosphamide; Disease Models, Animal; Dog Diseases; Dogs; Hepatic Veno-Occlusive Disease; Liver; Melphalan; Methionine Sulfoximine; Methotrexate; Monocrotaline; Pyrrolizidine Alkaloids; Radiation Injuries, Experimental; Radiography | 1987 |
Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
Topics: Animals; Buthionine Sulfoximine; Cells, Cultured; Cricetinae; Cricetulus; Drug Synergism; Etanidazole; Melphalan; Methionine Sulfoximine; Misonidazole; Nitroimidazoles; Oxygen; Sulfhydryl Compounds | 1985 |
Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer.
Topics: Buthionine Sulfoximine; Cell Survival; Cisplatin; Female; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured | 1988 |
Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cell Survival; Cross-Linking Reagents; DNA; Drug Synergism; Glutathione; Humans; Melanoma; Melphalan; Methionine Sulfoximine; Tumor Cells, Cultured | 1988 |
Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
Topics: Animals; Buthionine Sulfoximine; Female; Glutathione; Humans; Male; Medulloblastoma; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1988 |
Reduced thiol content in L1210 cells treated with BSO increases DNA crosslinking by melphalan.
Topics: Animals; Buthionine Sulfoximine; Cells, Cultured; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Glutathione; Leukemia L1210; Melphalan; Methionine Sulfoximine; Mice; Sulfhydryl Compounds | 1987 |
Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Line; Cell Survival; Female; Glutathione; Humans; Male; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms; Sulfhydryl Compounds | 1986 |
Effects of glutathione depletion on the cytotoxicity of agents toward a human colonic tumour cell line.
Topics: Antimetabolites; Antineoplastic Agents, Phytogenic; Buthionine Sulfoximine; Cell Line; Cell Survival; Colonic Neoplasms; Drug Evaluation, Preclinical; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Naphthols; Naphthoquinones; Sesquiterpenes; Sesquiterpenes, Guaiane; Vitamin K | 1987 |
In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalan.
Topics: Animals; Bone Marrow; Buthionine Sulfoximine; Drug Synergism; Female; Glutathione; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred C3H | 1986 |
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Topics: Animals; Buthionine Sulfoximine; Colony-Forming Units Assay; Drug Resistance; Drug Synergism; Female; Glutathione; Histocytochemistry; Humans; Melphalan; Methionine Sulfoximine; Mice; Mice, Nude; Ovarian Neoplasms | 1987 |
Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Topics: Animals; Buthionine Sulfoximine; Drug Synergism; Glutathione; Leukemia L1210; Male; Melphalan; Methionine Sulfoximine; Mice; Thymidine | 1987 |
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
Topics: Buthionine Sulfoximine; Cell Line; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance; Drug Synergism; Female; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms | 1985 |
Chemosensitization: do thiols matter?
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Synergism; Melphalan; Methionine Sulfoximine; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Sulfhydryl Compounds | 1984 |
Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
Topics: Buthionine Sulfoximine; Cell Line; Cell Survival; Cystine; Drug Resistance; Drug Synergism; Female; Glutathione; Humans; Kinetics; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms | 1984 |
Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.
Topics: Animals; Buthionine Sulfoximine; Cells, Cultured; Drug Resistance; Female; Glutathione; Male; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred DBA; Neoplasms, Experimental | 1984 |
Radiation resistance in a melphalan-resistant subline of a rat mammary carcinoma.
Topics: Animals; Buthionine Sulfoximine; Cell Cycle; Cell Division; Cell Survival; Drug Resistance; Glutathione Peroxidase; Glutathione Transferase; Mammary Neoplasms, Experimental; Melphalan; Methionine Sulfoximine; Radiation Tolerance; Radiation-Sensitizing Agents; Rats; Tumor Cells, Cultured | 1994 |
In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
Topics: Alkylating Agents; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Cells; Buthionine Sulfoximine; Cell Survival; Chromatography, High Pressure Liquid; Colony-Forming Units Assay; Drug Resistance; Female; Glutathione; Hematopoietic Stem Cells; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Sarcoma, Experimental | 1993 |
Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.
Topics: Buthionine Sulfoximine; Cell Survival; Glutathione; Humans; Male; Melphalan; Methionine Sulfoximine; Prostatic Neoplasms; Tumor Cells, Cultured | 1993 |
Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Buthionine Sulfoximine; Cell Division; Dose-Response Relationship, Drug; Drug Resistance; Glutathione; Glutathione Transferase; Humans; Male; Melphalan; Methionine Sulfoximine; Prostatic Neoplasms; Tumor Cells, Cultured | 1993 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |